enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Omega-3-acid ethyl esters - Wikipedia

   en.wikipedia.org/wiki/Omega-3-acid_ethyl_esters

   Omega-3-acid ethyl esters are used in addition to changes in diet to reduce triglyceride levels in adults with severe (≥ 500 mg/dL) hypertriglyceridemia. [3] In the European Union and other major markets outside the US, omega-3-acid ethyl esters are indicated for hypertriglyceridemia by itself, or in combination with a statin for people with mixed dyslipidemia.

3. Category:Drugs acting on the cardiovascular system - Wikipedia

   en.wikipedia.org/wiki/Category:Drugs_acting_on...

   This category reflects the organization of Anatomical Therapeutic Chemical Classification System code C. Generally, drugs ... Omega-3-acid ethyl esters; Omega-3 ...

4. Category:Hypolipidemic agents - Wikipedia

   en.wikipedia.org/wiki/Category:Hypolipidemic_agents

   Combination lipid-lowering drugs (12 P) F. Fibrates (1 C, 4 P) P. PCSK9 inhibitors (6 P) S. ... Omega-3-acid ethyl esters; Omega-3-carboxylic acids; P. Phytosterol; R ...

5. Lipid-lowering agent - Wikipedia

   en.wikipedia.org/wiki/Lipid-lowering_agent

   Lipid-lowering agents, also sometimes referred to as hypolipidemic agents, cholesterol-lowering drugs, or antihyperlipidemic agents are a diverse group of pharmaceuticals that are used to lower the level of lipids and lipoproteins, such as cholesterol, in the blood (hyperlipidemia). The American Heart Association recommends the descriptor ...

6. Ethyl eicosapentaenoic acid - Wikipedia

   en.wikipedia.org/wiki/Ethyl_eicosapentaenoic_acid

   Ethyl eicosapentaenoic acid (E-EPA) was the second fish-oil drug to be approved, after omega-3-acid ethyl esters (GlaxoSmithKline's Lovaza, which was approved in 2004. [31] [7] [32]) Initial sales were not as robust as Amarin had hoped. The labels for the two drugs were similar, but doctors prescribed Lovaza for people who had triglycerides ...

7. PPAR agonist - Wikipedia

   en.wikipedia.org/wiki/PPAR_agonist

   PPARγ (gamma) is the main target of the drug class of thiazolidinediones (TZDs), used in diabetes mellitus and other diseases that feature insulin resistance. It is also mildly activated by certain NSAIDs (such as ibuprofen) and indoles, as well as from a number of natural compounds. Known inhibitors include the experimental agent GW-9662.